Y. Minowa

Identification of risk factors for venous thromboembolism and evaluation of Khorana venous thromboembolism risk assessment in Japanese lung cancer patients.

T. Shiga, Harumi Takahashi, T. Hama, 2019, Journal of cardiology.

Associations among plasma concentrations of regorafenib and its metabolites, adverse events, and ABCG2 polymorphisms in patients with metastatic colorectal cancers

K. Chìn, Hitoshi Sato, Masataka Tajima, 2021, Cancer Chemotherapy and Pharmacology.

Drug interactions between tyrosine kinase inhibitors (gefitinib and erlotinib) and warfarin: Assessment of international normalized ratio elevation characteristics and in vitro CYP2C9 activity

M. Nishio, T. Shiga, Harumi Takahashi, 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.